United States

Alexion Pharma LLC (TRMS)

Track

Ticker: TRMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Sale 8 Jun 2015
Value US$2,395,368.22 | Price 113.13 | Shares 12,146 (+37.1%)
Sale 8 Jun 2015
Value US$434,582.77 | Price 374.73 | Shares 9,205 (-25.4%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2015-06-09 2015-06-08 S Sale Williams Glen

SVP, Technical Operations

Officer
12,146 +37.1%
113.13
US$2,395,368 		12,146 +37.1% 113.13 US$2,395,368
2015-06-09 2015-06-08 S Sale Williams Glen

SVP, Technical Operations

Officer
9,205 -25.4%
374.73
US$434,583 		9,205 -25.4% 374.73 US$434,583
2015-05-08 2015-05-06 PlS Planned sale Williams Glen

SVP, Technical Operations

Officer
86,364 -32.2%
298.05
US$376,045 		86,364 -32.2% 298.05 US$376,045
2015-05-08 2015-05-06 PlS Planned sale Williams Glen

SVP, Technical Operations

Officer
100 -15.0%
206.97
US$20,697 		100 -15.0% 206.97 US$20,697
2015-05-08 2015-05-06 PlS Planned sale Williams Glen

SVP, Technical Operations

Officer
400 -37.5%
206.27
US$82,508 		400 -37.5% 206.27 US$82,508
2015-05-08 2015-05-06 PlS Planned sale Williams Glen

SVP, Technical Operations

Officer
400 -27.2%
204.94
US$81,976 		400 -27.2% 204.94 US$81,976
2015-05-08 2015-05-06 PlS Planned sale Williams Glen

SVP, Technical Operations

Officer
666 -31.2%
203.99
US$135,857 		666 -31.2% 203.99 US$135,857
2015-04-29 2015-04-27 PlS Planned sale Quinn Anthony

EVP, CMO & Head of R&D

Officer
10,000 -64.0%
110.00
US$1,100,000 		10,000 -64.0% 110.00 US$1,100,000
2015-04-17 2015-04-15 PlS Planned sale Quinn Anthony

EVP, CMO & Head of R&D

Officer
10,000 -39.0%
105.00
US$1,050,000 		10,000 -39.0% 105.00 US$1,050,000
2015-04-09 2015-04-08 PlS Planned sale Williams Glen

SVP, Technical Operations

Officer
39,863 -98.8%
96.08
US$3,830,037 		39,863 -98.8% 96.08 US$3,830,037
2015-04-09 2015-04-07 PlS Planned sale Williams Glen

SVP, Technical Operations

Officer
2,769 -85.5%
96.04
US$265,935 		2,769 -85.5% 96.04 US$265,935
2015-04-08 2015-04-06 PlS Planned sale Quinn Anthony

EVP, CMO & Head of R&D

Officer
29,503 -65.4%
93.76
US$2,766,201 		29,503 -65.4% 93.76 US$2,766,201
2015-03-13 2015-03-11 PlS Planned sale Heberlig Chris

SVP, Finance and Business Ops.

Officer
300 -43.5%
105.74
US$31,722 		300 -43.5% 105.74 US$31,722
2015-03-13 2015-03-11 PlS Planned sale Heberlig Chris

SVP, Finance and Business Ops.

Officer
1,510 -68.6%
104.57
US$157,901 		1,510 -68.6% 104.57 US$157,901
2015-03-13 2015-03-11 PlS Planned sale Heberlig Chris

SVP, Finance and Business Ops.

Officer
3,290 -59.9%
103.55
US$340,680 		3,290 -59.9% 103.55 US$340,680
2015-03-13 2015-03-11 PlS Planned sale Heberlig Chris

SVP, Finance and Business Ops.

Officer
900 -14.1%
102.46
US$92,214 		900 -14.1% 102.46 US$92,214
2015-03-13 2015-03-11 PlS Planned sale Heberlig Chris

SVP, Finance and Business Ops.

Officer
600 -8.6%
101.38
US$60,828 		600 -8.6% 101.38 US$60,828
2015-03-13 2015-03-11 PlS Planned sale Heberlig Chris

SVP, Finance and Business Ops.

Officer
900 -11.4%
100.44
US$90,396 		900 -11.4% 100.44 US$90,396
2015-02-19 2015-02-17 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
1,842 -100.0%
101.69
US$187,313 		1,842 -100.0% 101.69 US$187,313
2015-02-19 2015-02-17 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
16,716 -90.1%
100.74
US$1,683,970 		16,716 -90.1% 100.74 US$1,683,970
2015-02-19 2015-02-17 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
14,750 -44.3%
99.97
US$1,474,558 		14,750 -44.3% 99.97 US$1,474,558
2015-02-19 2015-02-17 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
8,989 -21.3%
98.85
US$888,563 		8,989 -21.3% 98.85 US$888,563
2015-01-09 2015-01-07 B Purchase BAKER JULIAN Non-Executive Director Large shareholder
1,000,000 +12.2%
94.19
US$94,190,000 		1,000,000 +12.2% 94.19 US$94,190,000
2015-01-09 2015-01-07 B Purchase BAKER FELIX Non-Executive Director Large shareholder
1,000,000 +12.2%
94.19
US$94,190,000 		1,000,000 +12.2% 94.19 US$94,190,000
2014-12-30 2014-12-29 PlS Planned sale Heberlig Chris

Group Vice President, Finance

Officer
300 -49.7%
93.04
US$27,912 		300 -49.7% 93.04 US$27,912
2014-12-30 2014-12-29 PlS Planned sale Heberlig Chris

Group Vice President, Finance

Officer
1,156 -65.7%
92.10
US$106,468 		1,156 -65.7% 92.10 US$106,468
2014-12-30 2014-12-29 PlS Planned sale Heberlig Chris

Group Vice President, Finance

Officer
2,844 -61.8%
91.34
US$259,771 		2,844 -61.8% 91.34 US$259,771
2014-12-30 2014-12-29 PlS Planned sale Heberlig Chris

Group Vice President, Finance

Officer
1,800 -28.1%
89.90
US$161,820 		1,800 -28.1% 89.90 US$161,820
2014-12-19 2014-12-17 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
26,960 -96.3%
90.06
US$2,428,018 		26,960 -96.3% 90.06 US$2,428,018
2014-12-19 2014-12-17 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
4,488 -13.8%
87.26
US$391,623 		4,488 -13.8% 87.26 US$391,623
2014-12-19 2014-12-17 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
13,536 -29.4%
87.55
US$1,185,077 		13,536 -29.4% 87.55 US$1,185,077
2014-12-19 2014-12-17 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
5,016 -9.8%
87.25
US$437,646 		5,016 -9.8% 87.25 US$437,646
2014-10-30 2014-10-30 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
22,904 -100.0%
80.11
US$1,834,839 		22,904 -100.0% 80.11 US$1,834,839
2014-10-30 2014-10-28 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
1,000 -100.0%
80.00
US$80,000 		1,000 -100.0% 80.00 US$80,000
2014-10-30 2014-10-28 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
1,500 -60.0%
80.00
US$120,000 		1,500 -60.0% 80.00 US$120,000
2014-09-19 2014-09-19 PlS Planned sale Goldberg Mark Alan

EVP, Medical & Reg. Strategy

Officer
790 -58.4%
65.24
US$51,540 		790 -58.4% 65.24 US$51,540
2014-09-18 2014-09-17 PlS Planned sale Goldberg Mark Alan

EVP, Medical & Reg. Strategy

Officer
4,200 -88.2%
65.06
US$273,252 		4,200 -88.2% 65.06 US$273,252
2014-09-18 2014-09-16 PlS Planned sale Goldberg Mark Alan

EVP, Medical & Reg. Strategy

Officer
9,379 -94.3%
65.01
US$609,729 		9,379 -94.3% 65.01 US$609,729
2014-09-04 2014-09-02 PlS Planned sale Quinn Anthony

EVP, CMO & Head of R&D

Officer
300 -1.2%
72.88
US$21,864 		300 -1.2% 72.88 US$21,864
2014-09-04 2014-09-02 PlS Planned sale Quinn Anthony

EVP, CMO & Head of R&D

Officer
700 -2.6%
71.96
US$50,372 		700 -2.6% 71.96 US$50,372
2014-09-04 2014-09-02 PlS Planned sale Quinn Anthony

EVP, CMO & Head of R&D

Officer
400 -1.5%
70.50
US$28,200 		400 -1.5% 70.50 US$28,200
2014-09-04 2014-09-02 PlS Planned sale Quinn Anthony

EVP, CMO & Head of R&D

Officer
8,600 -24.2%
69.88
US$600,968 		8,600 -24.2% 69.88 US$600,968
2014-06-26 2014-06-25 PlS Planned sale Williams Glen

SVP, Technical Operations

Officer
700 -72.5%
108.02
US$75,614 		700 -72.5% 108.02 US$75,614
2014-06-24 2014-06-20 PlS Planned sale Quart Barry D Non-Executive Director
1,375 -100.0%
100.00
US$137,500 		1,375 -100.0% 100.00 US$137,500
2014-06-19 2014-06-17 PlS Planned sale Quart Barry D Non-Executive Director
1,000 -100.0%
90.00
US$90,000 		1,000 -100.0% 90.00 US$90,000
2014-06-16 2014-06-12 PlS Planned sale Quart Barry D Non-Executive Director
1,000 -100.0%
83.31
US$83,310 		1,000 -100.0% 83.31 US$83,310
2014-06-12 2014-06-11 PlS Planned sale Goldberg Mark Alan

EVP, Medical & Reg. Strategy

Officer
21,597 -97.9%
80.00
US$1,727,760 		21,597 -97.9% 80.00 US$1,727,760
2014-05-20 2014-05-16 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
200 -100.0%
83.46
US$16,692 		200 -100.0% 83.46 US$16,692
2014-05-20 2014-05-16 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
1,591 -88.8%
82.71
US$131,592 		1,591 -88.8% 82.71 US$131,592
2014-05-20 2014-05-16 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
8,136 -82.0%
81.75
US$665,118 		8,136 -82.0% 81.75 US$665,118
2014-04-03 2014-04-01 PlS Planned sale Quinn Anthony

EVP, CMO & Head of R&D

Officer
1,050 -6.3%
85.76
US$90,048 		1,050 -6.3% 85.76 US$90,048
2014-04-03 2014-04-01 PlS Planned sale Quinn Anthony

EVP, CMO & Head of R&D

Officer
4,746 -22.3%
84.72
US$402,081 		4,746 -22.3% 84.72 US$402,081
2014-04-03 2014-04-01 PlS Planned sale Quinn Anthony

EVP, CMO & Head of R&D

Officer
3,529 -14.2%
83.50
US$294,672 		3,529 -14.2% 83.50 US$294,672
2014-04-03 2014-04-01 PlS Planned sale Quinn Anthony

EVP, CMO & Head of R&D

Officer
10,675 -30.1%
82.80
US$883,890 		10,675 -30.1% 82.80 US$883,890
2014-03-14 2014-03-12 PlS Planned sale Heberlig Chris

Group Vice President, Finance

Officer
3,037 -94.1%
99.08
US$300,906 		3,037 -94.1% 99.08 US$300,906
2014-03-14 2014-03-12 PlS Planned sale Heberlig Chris

Group Vice President, Finance

Officer
3,933 -54.9%
98.49
US$387,361 		3,933 -54.9% 98.49 US$387,361
2014-03-14 2014-03-12 PlS Planned sale Heberlig Chris

Group Vice President, Finance

Officer
700 -8.9%
96.75
US$67,725 		700 -8.9% 96.75 US$67,725
2014-03-07 2014-03-06 B Purchase BAKER FELIX Non-Executive Director Large shareholder
9,031 +4.5%
105.75
US$955,028 		9,031 +4.5% 105.75 US$955,028
2014-03-07 2014-03-06 B Purchase BAKER JULIAN Non-Executive Director Large shareholder
9,031 +4.5%
105.75
US$955,028 		9,031 +4.5% 105.75 US$955,028
2014-03-07 2014-03-06 B Purchase BAKER FELIX Non-Executive Director Large shareholder
365,969 +4.7%
105.75
US$38,701,222 		365,969 +4.7% 105.75 US$38,701,222
2014-03-07 2014-03-06 B Purchase BAKER JULIAN Non-Executive Director Large shareholder
365,969 +4.7%
105.75
US$38,701,222 		365,969 +4.7% 105.75 US$38,701,222
2014-02-20 2014-02-18 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
894 -100.0%
104.22
US$93,173 		894 -100.0% 104.22 US$93,173
2014-02-20 2014-02-18 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
1,745 -66.1%
103.05
US$179,822 		1,745 -66.1% 103.05 US$179,822
2014-02-20 2014-02-18 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
3,207 -54.9%
102.18
US$327,691 		3,207 -54.9% 102.18 US$327,691
2014-02-20 2014-02-18 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
3,081 -34.5%
101.14
US$311,612 		3,081 -34.5% 101.14 US$311,612
2014-02-20 2014-02-18 PlS Planned sale BOESS CARSTEN

SVP, Chief Financial Officer

Officer
1,000 -10.1%
100.07
US$100,070 		1,000 -10.1% 100.07 US$100,070
2014-01-30 2014-01-29 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
400 -28.0%
91.58
US$36,632 		400 -28.0% 91.58 US$36,632
2014-01-30 2014-01-29 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
1,502 -51.2%
90.85
US$136,457 		1,502 -51.2% 90.85 US$136,457
2014-01-30 2014-01-29 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
5,600 -65.6%
89.27
US$499,912 		5,600 -65.6% 89.27 US$499,912
2014-01-30 2014-01-29 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
18,652 -68.6%
88.31
US$1,647,158 		18,652 -68.6% 88.31 US$1,647,158
2014-01-30 2014-01-29 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
24,817 -47.7%
87.19
US$2,163,794 		24,817 -47.7% 87.19 US$2,163,794
2014-01-30 2014-01-28 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
812 -44.1%
90.10
US$73,161 		812 -44.1% 90.10 US$73,161
2014-01-30 2014-01-28 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
8,402 -82.0%
88.95
US$747,358 		8,402 -82.0% 88.95 US$747,358
2014-01-30 2014-01-28 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
32,609 -76.1%
88.38
US$2,881,983 		32,609 -76.1% 88.38 US$2,881,983
2014-01-30 2014-01-28 PlS Planned sale Patel Sanj K

President & CEO

Executive Director
9,506 -18.2%
87.16
US$828,543 		9,506 -18.2% 87.16 US$828,543
Explore more

More insider trading research around Alexion Pharma LLC

More insider trades in United States
Insider trading in North America